Peptide-Based Hydrogels and Nanogels for Delivery of Doxorubicin

INTRODUCTION: The clinical use of the antitumoral drug doxorubicin (Dox) is reduced by its dose-limiting toxicity, related to cardiotoxic side effects and myelosuppression. In order to overcome these drawbacks, here we describe the synthesis, the structural characterization and the in vitro cytotoxi...

Descripción completa

Detalles Bibliográficos
Autores principales: Gallo, Enrico, Diaferia, Carlo, Rosa, Elisabetta, Smaldone, Giovanni, Morelli, Giancarlo, Accardo, Antonella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7935351/
https://www.ncbi.nlm.nih.gov/pubmed/33688182
http://dx.doi.org/10.2147/IJN.S296272

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7935351/
https://www.ncbi.nlm.nih.gov/pubmed/33688182
http://dx.doi.org/10.2147/IJN.S296272

Ejemplares similares